Welcome to the Oncomine Blog
Genomic Profiling from Initial Assessment to Detection of Measurable Residual Disease (MRD): How NGS Can Rapidly Deliver Key Insights for Myeloid Neoplasms
10/27/2022 |
Hemato-oncology
In his recent webinar, Dr. Bevan Tandon makes a compelling case for how next-generation sequencing (NGS) can deliver rapid insights for myeloid...
-
Let’s Do It Ourselves - A global expert consensus is emerging: by retaining oncology biomarker testing in-house, healthcare management and patient care benefit significantly
Over the last decade, precision oncology therapies dependent on biomarker-based diagnostics have pro... -
A Comprehensive Answer for Cancer: Is Comprehensive Genomic Profiling Always the Right Approach?
What is comprehensive genomic profiling (CGP)? CGP is the simultaneous detection of all classes of g... -
Biomarker Tests for Precision Oncology: DIY or Pay-for-Service?
Cancer patient management of is increasingly driven by biomarker assays – but how should we manage t... -
Evaluating the Oncomine Myeloid Assay GX for Detection of Key Variants
Dr. Yi Ding of Geisinger Medical Laboratories recently presented at the 2020 Association of Molecula... -
What is Comprehensive Genomic Profiling & is it the Right Solution for You?
What is comprehensive genomic profiling? Comprehensive genomic profiling, or CGP, is the simultaneou... -
The Importance of Detecting Copy Number Variants (CNVs) in the Cancer Genome
Structural variants in the cancer genome Gene amplification (copy number gain) and deletion (copy nu... -
Breakthrough Device Designation for Oncomine Dx Precision Test Provides Insights into Brain Tumors Fueled by a Common Genetic Mutation
Philip Scard knew immediately and intimately that the June 15 news release from Thermo Fisher Scient... -
The Impact of NGS in Hematology-Oncology
In aggressive forms of cancer such as acute myeloid leukemia (AML), accurate diagnosis is needed as ... -
The OncomineWorld Experience from Behind the Curtain
BACKGROUND: There is little to no point in saying that we are all living in an unprecedented time, ...